CIZ.L
Cizzle Biotechnology Holdings Plc
1W: +11.3%
1M: +49.7%
3M: +31.5%
YTD: +40.0%
1Y: +11.3%
3Y: +14.2%
£2.50 ($0.03)
+0.25 (+11.11%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap£8.9M ($0.1M)
52W Range1.2-2.5
Volume1,849,764
Avg Volume613,079
Beta0.51
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAllan John Syms
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2021-05-14
Websitecizzlebiotechnology.com
60 Gracechurch Street
London EC3V 0HR
GB
London EC3V 0HR
GB
44 20 3934 6630
About Cizzle Biotechnology Holdings Plc
Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Recent Insider Trades
No insider trades found